Farmacia e farmacoloxía
Servizo
Complexo Hospitalario Universitario de Vigo
Vigo, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (35)
2023
-
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593
-
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1
Journal of Infectious Diseases
-
Real-world evidence of sorafenib for the treatment of hepatocellular carcinoma: A single-center study
Journal of Cancer Research and Therapeutics, Vol. 19, Núm. 5, pp. 1345-1349
2022
-
Clinical usefulness of serum angiotensin converting enzyme in silicosis
Pulmonology
-
Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control
The Journal of infectious diseases, Vol. 225, Núm. 6, pp. 1040-1049
-
Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion
Pharmaceuticals, Vol. 15, Núm. 1
-
Regorafenib and trifluridine/tipiracil in real clinical practice
Journal of cancer research and therapeutics, Vol. 18, pp. S367-S373
-
Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review
British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1529-1550
2021
-
Direct costs in patients with chronic inflammatory arthropathies on biological therapy: A real-world data study
Clinical and Experimental Rheumatology, Vol. 39, Núm. 4, pp. 736-745
-
Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice
Clinical Therapeutics, Vol. 43, Núm. 4, pp. e111-e121
-
Fitofotodermatitis
FMC: Formación Médica Continuada en Atención Primaria, Vol. 28, Núm. 10, pp. 573-575
-
Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study
European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E47-E50
-
Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments
Journal of Clinical Pharmacy and Therapeutics, Vol. 46, Núm. 3, pp. 724-730
-
Serum levels of inflammatory mediators as prognostic biomarker in silica exposed workers
Scientific reports, Vol. 11, Núm. 1, pp. 13348
-
Stability of lipid emulsion in total parenteral nutrition: An overview of literature
Clinical Nutrition ESPEN, Vol. 45, pp. 19-25
2020
-
Standardization Consensus of a Hospital Drug Database: An Efficient Tool
Therapeutic Innovation and Regulatory Science, Vol. 54, Núm. 1, pp. 85-92
2019
-
Adherence to biological therapies in patients with chronic inflammatory arthropathies
Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139
-
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
Basic and Clinical Pharmacology and Toxicology, Vol. 124, Núm. 4, pp. 479-490
2018
-
Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care
Therapeutic Innovation and Regulatory Science, Vol. 52, Núm. 1, pp. 94-99
-
Standardization Consensus of a Hospital Drug Database: An Efficient Tool
Therapeutic Innovation and Regulatory Science